When a Patient Asks ChatGPT About Their Diagnosis, Who Answers?
In 2023, a 54-year-old woman in Phoenix typed a question into ChatGPT that her endocrinologist hadn’t fully answered to her […]
In 2023, a 54-year-old woman in Phoenix typed a question into ChatGPT that her endocrinologist hadn’t fully answered to her […]
When a physician in Ohio types “best GLP-1 for weight loss” into Perplexity and receives a two-paragraph synthesis with no
ChatGPT has told patients that Ozempic is FDA-approved for weight loss in children. Gemini has cited drug interaction warnings that
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will
When a patient types “is Ozempic safe for someone with a history of pancreatitis?” into ChatGPT, they get an answer
Most pharmaceutical companies still don’t know what ChatGPT says about their drugs. They don’t know whether Perplexity recommends their biologic
A patient with rheumatoid arthritis does not always call her rheumatologist first anymore. She opens ChatGPT and asks whether switching
Artificial intelligence is beginning to change not only how patients search for information about medicines, but also how journalists research
A patient asks ChatGPT if it is safe to skip a dose of a heart medication because they feel dizzy.
A physician in Cincinnati asks ChatGPT whether semaglutide reduces cardiovascular events in patients without diabetes. The AI answers confidently, citing
Every day, millions of patients type questions about their prescriptions into ChatGPT, Perplexity, Gemini, and Claude. They ask whether Ozempic
Ask ChatGPT whether Ozempic is safe for patients with a history of pancreatitis. Then ask Gemini. Then ask Perplexity. You
Get sharp analysis on AI-generated drug information, off-label curiosity, pharmacovigilance blind spots, and the shifting intersection of pharma, search, and large language models. No fluff. Just the signals that matter.